Towerman AS - Search Results

1

Epstein-Barr virus-induced sickle hepatopathy.

Towerman AS, Wilson DB, Hulbert ML. Towerman AS, et al. Pediatr Blood Cancer. 2021 Sep;68(9):e29196. doi: 10.1002/pbc.29196. Epub 2021 Jun 27. Pediatr Blood Cancer. 2021. PMID: 34180131

2

Prevalence and nature of hearing loss in a cohort of children with sickle cell disease.

Towerman AS, Hayashi SS, Hayashi RJ, Hulbert ML. Towerman AS, et al. Pediatr Blood Cancer. 2019 Jan;66(1):e27457. doi: 10.1002/pbc.27457. Epub 2018 Sep 11. Pediatr Blood Cancer. 2019. PMID: 30207054

3

A Case Series of Kawasaki Disease in Children With Sickle Cell Disease.

Towerman AS, Reich PJ, Hulbert ML. Towerman AS, et al. J Pediatr Hematol Oncol. 2022 Apr 1;44(3):103-105. doi: 10.1097/MPH.0000000000002308. J Pediatr Hematol Oncol. 2022. PMID: 34486560

4

Normalization of cerebral hemodynamics after hematopoietic stem cell transplant in children with sickle cell disease.

Hulbert ML, Fields ME, Guilliams KP, Bijlani P, Shenoy S, Fellah S, Towerman AS, Binkley MM, McKinstry RC, Shimony JS, Chen Y, Eldeniz C, Ragan DK, Vo K, An H, Lee JM, Ford AL. Hulbert ML, et al. Among authors: towerman as. Blood. 2023 Jan 26;141(4):335-344. doi: 10.1182/blood.2022016618. Blood. 2023. PMID: 36040484 Free PMC article.

5

Early Identification of Barriers and Facilitators to Self-Management Behaviors in Pediatric Patients With Sickle Cell Disease to Minimize Hematopoietic Cell Transplantation Complications.

Schulz GL, Foster RH, Kennedy Lang V, Towerman A, Shenoy S, Lauer BA, Molzon E, Holtmann M. Schulz GL, et al. J Pediatr Oncol Nurs. 2018 May;35(3):199-209. doi: 10.1177/1043454218762703. Epub 2018 Mar 26. J Pediatr Oncol Nurs. 2018. PMID: 29577801

6

CD34-selected stem cell boost as therapy for late graft rejection following allogeneic transplantation for sickle cell disease.

Rangarajan HG, Crowell SA, Towerman AS, Shenoy SS. Rangarajan HG, et al. Among authors: towerman as. Bone Marrow Transplant. 2022 Oct;57(10):1592-1594. doi: 10.1038/s41409-022-01749-9. Epub 2022 Jul 7. Bone Marrow Transplant. 2022. PMID: 35798858 No abstract available.

7

Correction to: CD34-selected stem cell boost as therapy for late graft rejection following allogeneic transplantation for sickle cell disease.

Rangarajan HG, Crowell SA, Towerman AS, Shenoy SS. Rangarajan HG, et al. Among authors: towerman as. Bone Marrow Transplant. 2022 Dec;57(12):1855. doi: 10.1038/s41409-022-01854-9. Bone Marrow Transplant. 2022. PMID: 36261709 No abstract available.

8

From the Children's Oncology Group: Evidence-Based Recommendations for PEG-Asparaginase Nurse Monitoring, Hypersensitivity Reaction Management, and Patient/Family Education.

Woods D, Winchester K, Towerman A, Gettinger K, Carey C, Timmermann K, Langley R, Browne E. Woods D, et al. J Pediatr Oncol Nurs. 2017 Nov/Dec;34(6):387-396. doi: 10.1177/1043454217713455. Epub 2017 Jun 10. J Pediatr Oncol Nurs. 2017. PMID: 28602129 Free PMC article. Review.

9

Hyperammonemia and acute liver failure associated with deferasirox in two adolescents with sickle cell disease.

Towerman AS, Guilliams KP, Guerriero R, Shinawi MS, Stoll JM, Willis DN, Hulbert ML. Towerman AS, et al. Br J Haematol. 2023 May;201(4):e30-e33. doi: 10.1111/bjh.18770. Epub 2023 Mar 25. Br J Haematol. 2023. PMID: 36964994 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

9 results

Search Page

Filters